CIBC World Market’s BioMarin Pharmaceuticals BMRN Stock Holding History

CIBC World Market’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,660	Closed	-$2.04M	–	1240
2022 Q4	$2.04M	Buy	+19,660	New	+$1.85M	0.01%	577
2020 Q3	–	Sell	-10,726	Closed	-$1.32M	–	1094
2020 Q2	$1.32M	Buy	+10,726	New	+$1.07M	0.01%	575
2018 Q2	–	Sell	-2,620	Closed	-$212K	–	1149
2018 Q1	$212K	Hold	2,620	–	–	﹤0.01%	1079
2017 Q4	$234K	Sell	2,620 -68	-3%	-$5.91K	﹤0.01%	721
2017 Q3	$250K	Sell	2,688 -5,072	-65%	-$448K	﹤0.01%	673
2017 Q2	$705K	Hold	7,760	–	–	﹤0.01%	737
2017 Q1	$681K	Buy	+7,760	New	+$690K	﹤0.01%	668

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC World Market's BMRN Position: Q1 2023 in Review

CIBC World Market sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2023, closing a stake of 19,660 shares — an estimated $2.04M sold.

CIBC World Market first reported a position in BMRN in Q1 2017 and held it in 7 quarters. The position peaked at $2.04M in Q4 2022. 552 funds tracked by Wall St. Rank hold BMRN as of Q1 2023.

CIBC World Market reported no remaining BioMarin Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
CIBC World Market sold 19,660 BioMarin Pharmaceuticals shares in Q1 2023, an estimated $2.04M.
CIBC World Market first reported a position in BioMarin Pharmaceuticals in Q1 2017 and held it in 7 quarters.
CIBC World Market's BioMarin Pharmaceuticals position peaked at $2.04M in Q4 2022.
552 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2023.

Based on CIBC World Market's 13F filing for Q1 2023, filed 12 May 2023.